Lloyd Park’s Merck MRK Stock Holding History

Lloyd Park’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19,600	Closed	-$1.5M	–	82
2021 Q4	$1.5M	Buy	+19,600	New	+$1.56M	0.84%	23

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lloyd Park's MRK Position: Q1 2022 in Review

Lloyd Park sold out of Merck (MRK) in Q1 2022, closing a stake of 19,600 shares — an estimated $1.5M sold.

Lloyd Park first reported a position in MRK in Q4 2021 and held it in 1 quarter. The position peaked at $1.5M in Q4 2021. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Lloyd Park reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
Lloyd Park sold 19,600 Merck shares in Q1 2022, an estimated $1.5M.
Lloyd Park first reported a position in Merck in Q4 2021 and held it in 1 quarter.
Lloyd Park's Merck position peaked at $1.5M in Q4 2021.
2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Lloyd Park's 13F filing for Q1 2022, filed 3 May 2022.